Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « AbsEn.i » - entrée « reported »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
report < reported < reportedly  Facettes :

List of bibliographic references indexed by reported

Number of relevant bibliographic references: 191.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000022 (2021) E. Díaz [Espagne] ; R. Amézaga Menéndez [Espagne] ; P. Vidal Cortés [Espagne] ; M G Escapa [Espagne] ; B. Suberviola [Espagne] ; A. Serrano Lázaro [Espagne] ; P. Marcos Neira [Espagne] ; M. Quintana Díaz [Espagne] ; M. Catalán González [Espagne][Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH)].
000023 (2021) Consuelo Luna-Mu Oz [Pérou] ; Giuliana Reyes-Florian [Pérou] ; Martin Seminario-Aliaga [Pérou] ; Angie Stapleton-Herbozo [Pérou] ; Lucy E. Correa-L Pez [Pérou] ; Dante M. Qui Ones-Laveriano [Pérou][Pediatric inflammatory multisystem syndrome associated with COVID-19: A report of 10 cases in a Peruvian hospital].
000051 (2021) Tahani Bin Ali ; Ghaleb Elyamany ; Maha Nojoom ; Mohamed Alfaki ; Hassan Alahmari ; Abdulwahab Alharthi ; Muwaffak Hijazi ; Atif Alsahari ; Fahad Alabbas ; Abdulnasir Al-Otaibi [Arabie saoudite]Unusual presentation of COVID-19 in a child complicated by massive acute pulmonary embolism and lung infarction.
000087 (2021) Romain Lutaud [France] ; Dimiti Scronias [France] ; Jeremy Ward [France] ; Pierre Verger [France]The hydroxychloroquine debate: a therapeutic dilemma for general practitioners.
000094 (2021) Subham Das [Inde] ; Anu Kunnath Ramachandran [Inde] ; Sumit Raosaheb Birangal [Inde] ; Saleem Akbar [Inde] ; Bahar Ahmed [Inde] ; Alex Joseph [Inde]The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review.
000103 (2021) Rana Aljadeed [Arabie saoudite] ; Yazed Alruthia [Arabie saoudite] ; Bander Balkhi [Arabie saoudite] ; Ibrahim Sales [Arabie saoudite] ; Monira Alwhaibi [Arabie saoudite] ; Omar Almohammed [Arabie saoudite] ; Abdulaziz J. Alotaibi [Arabie saoudite] ; Ali M. Alrumaih [Arabie saoudite] ; Yousif Asiri [Arabie saoudite]The Impact of COVID-19 on Essential Medicines and Personal Protective Equipment Availability and Prices in Saudi Arabia.
000104 (2021) Farah Daou [Liban] ; Gretta Abou-Sleymane [Liban] ; Danielle A. Badro [Liban] ; Nagham Khanafer [France] ; Mansour Tobaiqy [Arabie saoudite] ; Achraf Al Faraj [Liban]The History, Efficacy, and Safety of Potential Therapeutics: A Narrative Overview of the Complex Life of COVID-19.
000108 (2021) Masashi Ohe [Japon] ; Ken Furuya [Japon] ; Houman Goudarzi [Japon]Tetracycline plus macrolide: A potential therapeutic regimen for COVID-19?
000125 (2021) Andy Sing Ong Tang ; Tze Shin Leong ; Lee Ping Chew ; Hock Hin ChuaSuccessful Non-surgical Treatment of an Acute Calculous Cholecystitis in a Myeloma Patient with Covid-19: Case Report.
000146 (2021) Rahul Sharma [Inde] ; Dharmendra Khokhar [Inde] ; Bhanushree Gupta [Inde] ; Purnendu Saxena [Inde] ; Kallol Kumar Ghosh [Inde] ; Arvind Kumar Geda [Inde] ; Kamil KucaSevere Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2): A Review on Pathophysiology, Diagnosis and Investigational Therapeutics.
000153 (2021) Kavita Manchanda [Inde] ; Jasbir Singh [Inde] ; Ranjeev Bhagat [Inde] ; Ilmjot Kaur Tiwana [Inde] ; Harmanjit Singh [Inde]Safety of pharmacological options for the management of COVID-19 in pregnant women: An Indian perspective.
000158 (2021) Hany M. Dabbous [Égypte] ; Manal H. El-Sayed [Égypte] ; Gihan El Assal [Égypte] ; Hesham Elghazaly [Égypte] ; Fatma F S. Ebeid [Égypte] ; Ahmed F. Sherief [Égypte] ; Maha Elgaafary [Égypte] ; Ehab Fawzy [Égypte] ; Sahar M. Hassany [Égypte] ; Ahmed R. Riad [Égypte] ; Mohamed A. Tageldin [Égypte]Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial.
000167 (2021) Masoomeh Sofian [Iran] ; Ali Akbar Velayati [Iran] ; Mohammad Banifazl [Iran] ; Fatemeh Fotouhi [Iran] ; Mona Sadat Larijani [Iran] ; Neda Afzali [Iran] ; Amitis Ramezani [Iran]SARS-CoV‑2, a virus with many faces: a series of cases with prolonged persistence of COVID-19 symptoms.
000206 (2021) Justine Perez ; Matthieu Roustit ; Marion Lepelley ; Bruno Revol ; Jean-Luc Cracowski ; Charles KhouriReported Adverse Drug Reactions Associated With the Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic.
000215 (2021) Alexandre O. Gérard [France] ; Audrey Laurain [France] ; Audrey Fresse [France] ; Nadège Parassol [France] ; Marine Muzzone [France] ; Fanny Rocher [France] ; Vincent L M. Esnault [France] ; Milou-Daniel Drici [France]Remdesivir and Acute Renal Failure: A Potential Safety Signal From Disproportionality Analysis of the WHO Safety Database.
000233 (2021) Olfa Noureddine [Tunisie] ; Noureddine Issaoui [Tunisie] ; Mouna Medimagh [Tunisie] ; Omar Al-Dossary [Arabie saoudite] ; Houda Marouani [Tunisie]Quantum chemical studies on molecular structure, AIM, ELF, RDG and antiviral activities of hybrid hydroxychloroquine in the treatment of COVID-19: Molecular docking and DFT calculations.
000264 (2021) Yanqiang Han ; Zhilong Wang ; Jiahao Ren ; Zhiyun Wei ; Jinjin Li [République populaire de Chine]Potential inhibitors for the novel coronavirus (SARS-CoV-2).
000265 (2021) Gayathri Baburaj [Inde] ; Levin Thomas [Inde] ; Mahadev Rao [Inde]Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies.
000280 (2021) Ingrid Fricke-Galindo [Mexique] ; Ramcés Falfán-Valencia [Mexique]Pharmacogenetics Approach for the Improvement of COVID-19 Treatment.
000293 (2021) Maziar Emamikhah [Iran] ; Mansoureh Babadi [Iran] ; Mehrnoush Mehrabani [Iran] ; Mehdi Jalili [Iran] ; Maryam Pouranian [Iran] ; Peyman Daraie [Iran] ; Fahimeh Mohaghegh [Iran] ; Sharmin Aghavali [Iran] ; Maryam Zaribafian [Iran] ; Mohammad Rohani [Iran]Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.
000299 (2021) Marko Boban [Croatie]Novel coronavirus disease (COVID-19) update on epidemiology, pathogenicity, clinical course and treatments.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "reported" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "reported" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    reported
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021